Myeloma News — June 23, 2022
New data from a new bispecific antibody targeting GPR5CD called talquetamab is now available.
Life with Myeloma—June 22, 2022
The HealthTree Moves for Myeloma Columbus, Ohio race was a fabulous event to get together and raise funds for myeloma research.
Myeloma News—June 17, 2022
The bispecific antibody teclistamab is getting closer to FDA approval for multiple myeloma patients. Here's updated data from recent myeloma conferences.
Life with Myeloma—June 16, 2022
What is Juneteenth? HealthTree Foundation for Multiple Myeloma is celebrating in a Juneteenth Virtual Tour
Myeloma News—June 14, 2022
The flood of bispecific antibodies is coming, with new data emerging from the recent EHA meeting